- Front-line treatment of advanced non-small-cell lung cancer with docetaxel and gemcitabine: a multicenter phase II trial. Georgoulias, V., Kouroussis, C., Androulakis, N., Kakolyris, S., Dimopoulos, M.A., Papadakis, E., Bouros, D., Apostolopoulou, F., Papadimitriou, C., Agelidou, A., Hatzakis, K., Kalbakis, K., Kotsakis, A., Vardakis, N., Vlachonicolis, J. J. Clin. Oncol. (1999)